Suppr超能文献

胸膜疾病

Pleural diseases.

作者信息

Light R W

机构信息

University of California, Irvine.

出版信息

Dis Mon. 1992 May;38(5):266-331. doi: 10.1016/0011-5029(92)90007-c.

Abstract

In the United States, approximately one million patients each year develop a pleural effusion. Pleural effusions have classically been divided into transudative and exudative pleural effusions. A transudative pleural effusion occurs when the systemic factors influencing pleural fluid formation and reabsorption are altered so that pleural fluid accumulates; an exudative pleural effusion occurs when the local factors influencing pleural fluid formation and reabsorption are altered, allowing accumulation of pleural fluid. The leading causes of transudative pleural effusions are left ventricular failure and cirrhosis with ascites. The leading causes of exudative pleural effusions are pneumonia, malignancy, and pulmonary embolization. Transudative pleural effusions can be differentiated from exudative pleural effusions by measurement of the pleural fluid protein and lactic dehydrogenase (LDH) levels. The ratio of the pleural fluid protein to the serum protein is less than 0.5, the ratio of the pleural fluid LDH to the serum LDH is less than 0.6, and the absolute value of the pleural fluid LDH level is less than two thirds of the upper normal limit for serum with transudative pleural effusions while at least one of these criteria is not met with exudative effusions. Most patients who have a pleural effusion with congestive heart failure have left ventricular failure. It is believed that the transudation of the pulmonary interstitial fluid across the visceral pleura overwhelms the capacity of the lymphatics to remove the fluid. Most patients with cirrhosis who have a pleural effusion also have ascites. It is also believed that the pleural effusions form when fluid moves directly from the peritoneal cavity into the pleural cavity through pores in the diaphragm. Approximately 40% of patients with pneumonia will have a pleural effusion. If these patients have a significant amount of pleural fluid, a diagnostic thoracentesis should be performed. Chest tubes should be inserted if the pleural fluid is gross pus, if the Gram stain of the pleural fluid is positive, if the pleural fluid glucose level is below 40 mg/dl, or if the pleural fluid pH level is less than 7.00. If drainage with the chest tubes is unsatisfactory, either streptokinase or urokinase should be injected intrapleurally. If drainage is still unsatisfactory, a decortication should be considered. The three leading malignancies that have an associated pleural effusion are breast carcinoma, lung carcinoma, lymphomas and leukemias. The diagnosis of pleural malignancy is made most commonly with pleural fluid cytology; in recent years immunohistochemical tests have proved invaluable in differentiating benign from malignant pleural effusions.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在美国,每年约有100万患者出现胸腔积液。传统上,胸腔积液分为漏出性胸腔积液和渗出性胸腔积液。当影响胸腔积液形成和重吸收的全身因素发生改变导致胸腔积液积聚时,就会出现漏出性胸腔积液;当影响胸腔积液形成和重吸收的局部因素发生改变,使得胸腔积液得以积聚时,则会出现渗出性胸腔积液。漏出性胸腔积液的主要病因是左心衰竭和伴有腹水的肝硬化。渗出性胸腔积液的主要病因是肺炎、恶性肿瘤和肺栓塞。通过检测胸腔积液中的蛋白质和乳酸脱氢酶(LDH)水平,可将漏出性胸腔积液与渗出性胸腔积液区分开来。漏出性胸腔积液时,胸腔积液蛋白质与血清蛋白质的比值小于0.5,胸腔积液LDH与血清LDH的比值小于0.6,且胸腔积液LDH水平的绝对值小于血清正常上限值的三分之二;而渗出性胸腔积液则至少不符合上述其中一项标准。大多数因充血性心力衰竭出现胸腔积液的患者存在左心衰竭。据信,肺间质液通过脏层胸膜的滤出超过了淋巴管清除液体的能力。大多数有胸腔积液的肝硬化患者也有腹水。人们还认为,当液体通过膈肌上的小孔直接从腹腔进入胸腔时,就会形成胸腔积液。约40%的肺炎患者会出现胸腔积液。如果这些患者胸腔积液量较大,应进行诊断性胸腔穿刺术。如果胸腔积液为脓性、胸腔积液革兰氏染色呈阳性、胸腔积液葡萄糖水平低于40mg/dl或胸腔积液pH值小于7.00,则应插入胸管。如果胸管引流效果不佳,应向胸腔内注射链激酶或尿激酶。如果引流仍不理想,则应考虑行胸膜剥脱术。与胸腔积液相关的三种主要恶性肿瘤是乳腺癌、肺癌、淋巴瘤和白血病。胸腔恶性肿瘤的诊断最常用胸腔积液细胞学检查;近年来,免疫组化检测在鉴别良性与恶性胸腔积液方面已证明具有极高价值。(摘要截选至400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验